Shaun R. Wood
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy.
Journal: Molecular therapy. Methods & clinical development
Published: July 18, 2023
Systemic immune challenge exacerbates neurodegeneration in a model of neurological lysosomal disease.
Journal: EMBO molecular medicine
Published: July 07, 2023
Delivering gene therapy for mucopolysaccharide diseases.
Journal: Frontiers in molecular biosciences
Published: June 09, 2022
A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1.
Journal: Human gene therapy methods
Published: April 10, 2019
Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA.
Journal: Molecular therapy. Methods & clinical development
Published: January 14, 2019
Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal Diseases.
Journal: ACS chemical neuroscience
Published: August 24, 2018
Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 05, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026